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Dauber et al., page 798
A typical pathogenic copy-number variant (CNV) alters
the dosage balance of several transcripts, a feature high-
lighted in the variety of phenotypes that can be attributed
to a single CNV. Although significant progress has been
made in determining the contribution of specific genes
that reside within recurrent CNVs, similar efforts in the
realm of nonrecurrent CNVs have met with much less suc-
cess. Now, through a combination of fine mapping and
studies in zebrafish, Dauber et al. were able to pinpoint
the genes whose loss contributes to discrete phenotypes
caused by deletion of 8q24.3. Their work uncovers a com-
plex genetic architecture: some phenotypes result from the
loss of a single transcript, whereas others stem from gene-
gene interactions. Moreover, the crucial genes identified,
PUF60 and SCRIB, although not previously implicated in
human disease, are individually well studied in the realm
of basic biology. Future work should be able to harness
this knowledge, thus enabling even greater insight into
the complex interplay between their gene products.
Although the authors’ approach relies on faithful pheno-
typic modeling in fish, this work serves as a roadmap for
how other investigators might approach CNV dissection
in an unbiased manner.Refining FMRP Targets Associated with ASD
Steinberg et al., page 825
Comorbidity and molecular evidence have provided hints
about the link between Fragile X syndrome (FXS), caused
by loss of function of FMRP, and autism spectrum disorder
(ASD). Because FMRP negatively regulates transcription
of bound mRNAs, it has been suggested that some of the
overlap between FXS and ASD might be caused by a misre-
gulation of FRMP and its targets; in fact, previous studies
have demonstrated that ASD candidate genes are enriched
with FMRP targets. To further refine how FMRP targets
might be involved in ASD, Steinberg et al. divided FMRP
targets into subgroups on the basis of spatiotemporal
expression patterns in the brain and looked for an associa-
tion between these modules and ASD candidate genes
by using a pathway association test named the Trend
test. Using this approach, they found that FMRP targets
are more likely to contribute to ASD than similarly ex-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The Americanpressed genes and that the risk of ASD increases as the
number of FMRP-target mutations increases. Moreover,
ASD-associated target genes with de novo mutations
are enriched with embryonically expressed transcripts,
including transcription factors and chromatin modifiers,
whereas genes disrupted by copy-number variants and
inherited mutations are brain-specific transcripts that are
highly expressed during adolescence and adulthood. This
evidence suggests that de novo mutations and inherited
mutations contribute differently to ASD and provides
some insight into the seemingly divergent pathways that
have been previously implicated in ASD.Improving Ancient DNA Capture
Carpenter et al., page 852
Where did we come from? Nothing captures the imagi-
nation quite like this question. Recent technological
advances, coupled with archaeological best practices,
have made it possible to address this question in ways
previously thought to be impossible. We now have full
genome sequences of several ancient humans (and ani-
mals). However, for each high-quality specimen, there
are numerous samples that, as a result of the vagaries of
time and contamination, contain very low levels of endog-
enous DNA. Indeed, for every Denisovan or O¨tzi, countless
samples remain sitting on shelves because they are unable
to be analyzed by current sequencing technologies. Now,
Carpenter et al. present a whole-genome capture-based
method that should enable researchers to obtain high-
quality sequence information from a variety of ancient
sources, including those recovered from environments
that, much to the chagrin of geneticists and archaeologists
alike, are not conducive to the preservation of ancient
DNA. The low cost associated with this method will
make it feasible to conduct population-level studies,
which, one can imagine, could begin to provide unprece-
dented views into the life and times of early man (as well
as his animal companions).SEQMIX: Off-Target, Low-Coverage Sequence to
Whole-Genome Ancestry in Admixed Individuals
Hu et al., page 891
Determining the ancestral blocks in the genome of
admixed individuals is useful for studies of humany of Human Genetics. All rights reserved.
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history and disease discovery. For example, admixture
mapping has provided new insights into several human
disorders. In many studies, targeted sequencing, such
as exome sequencing, is used for identifying variants
associated with a particular disease, but it also gene-
rates low-coverage, off-target sequences. Although this
approach is useful for the discovery of genetic variants,
ancestry-informative markers are often not available
and whole-genome ancestry cannot be inferred. In
this study, Hu et al. propose SEQMIX, a method that
uses off-target sequences generated from targeted
sequencing to determine whole-genome ancestry.
Combining the data from off-target sequences with an
average of 1.23–1.93 coverage and the sequence from
the targeted region, the authors could identify short
ancestry blocks in African Americans, allowing the
identification of the genomic regions that were
composed of European and African descent. Because
of the relatively recent timeframe in which the admix-
ture occurred, the off-target coverage required for accu-
racy was fairly low, but genomes with more ancient
admixture will probably require higher off-target
coverage to be useful because the ancestral blocks of
the genome are smaller. In the future, it will also be
interesting to determine whether SEQMIX can be
expanded for multiway admixtures in addition to two-
way admixtures.776 The American Journal of Human Genetics 93, 775–776, NovembA Painful Discovery
Zhang et al., page 957
Ouch! For most of us, a sense of pain originates from
injury—from that pesky paper cut to severe compound
fractures—or internal problems, such as migraine head-
aches. Although the exact neural circuits that bring about
this none-too-pleasant sensation are still being defined,
some clues about the underlying biology of pain come
from individuals who experience the spectrums of this
response. In this issue, Zhang et al. identified SCN11Amu-
tations in families who experience intense, episodic pain
accompanied by a feeling of cold in their lower extremities
in the absence of external insults. Expression of these var-
iants in mouse neurons induced hyperexcitability, lending
support to the idea that they function in a gain-of-function
manner. Interestingly, another group recently reported
that de novo mutations in this gene cause a phenotype
at the opposite end of the pain spectrum: in these families,
aberrant SCN11A activity causes a loss of pain perception,
leading to rather unpleasant outcomes for affected
individuals (Leipold et al. [2013]. Nat. Genet. 10.1038/
ng.2767.). These studies highlight the importance of
proper SCN11A function in generating appropriate re-
sponses to pain and together lay the foundation for
future studies aimed at delineating how SCN11A interacts
with other components of the nociception pathway.er 7, 2013
